The effect of sibutramine prescribing in routine clinical practice on cardiovascular outcomes: a cohort study in the United Kingdom

BACKGROUND/OBJECTIVES: The marketing authorization for the weight loss drug sibutramine was suspended in 2010 following a major trial that showed increased rates of non-fatal myocardial infarction and cerebrovascular events in patients with pre-existing cardiovascular disease. In routine clinical pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hayes, J F, Bhaskaran, K, Batterham, R, Smeeth, L, Douglas, I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551415/
https://www.ncbi.nlm.nih.gov/pubmed/25971925
http://dx.doi.org/10.1038/ijo.2015.86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551415/
https://www.ncbi.nlm.nih.gov/pubmed/25971925
http://dx.doi.org/10.1038/ijo.2015.86

Ejemplares similares